Literaturliste David Totschnig

Werbung
 Literaturliste David Totschnig 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. Shinagawa, T., et al., Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells. Cell Stem Cell, 2014. 14(2): p. 217‐27. Greggains, G.D., et al., Therapeutic potential of somatic cell nuclear transfer for degenerative disease caused by mitochondrial DNA mutations. Sci Rep, 2014. 4: p. 3844. Chung, Y.G., et al., Human somatic cell nuclear transfer using adult cells. Cell Stem Cell, 2014. 14(6): p. 777‐80. Firas, J., X. Liu, and J.M. Polo, Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: Evidence and implications. Differentiation, 2014. Fulka, J., Jr., et al., The ups and downs of somatic cell nucleus transfer (SCNT) in humans. J Assist Reprod Genet, 2013. 30(8): p. 1055‐8. Heffernan, C., et al., Induction of pluripotency. Adv Exp Med Biol, 2013. 786: p. 5‐25. Hyun, I., Moving human SCNT research forward ethically. Cell Stem Cell, 2011. 9(4): p. 295‐7. Krishnakumar, R. and R.H. Blelloch, Epigenetics of cellular reprogramming. Curr Opin Genet Dev, 2013. 23(5): p. 548‐55. Langerova, A., H. Fulka, and J. Fulka, Jr., Somatic cell nuclear transfer‐derived embryonic stem cell lines in humans: pros and cons. Cell Reprogram, 2013. 15(6): p. 481‐3. Ma, H., et al., Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature, 2014. 511(7508): p. 177‐83. Nippert, I., The pros and cons of human therapeutic cloning in the public debate. J Biotechnol, 2002. 98(1): p. 53‐60. Tachibana, M., et al., Human embryonic stem cells derived by somatic cell nuclear transfer. Cell, 2013. 153(6): p. 1228‐38. Watanabe, A., Y. Yamada, and S. Yamanaka, Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos Trans R Soc Lond B Biol Sci, 2013. 368(1609): p. 20120292. Yu, Y., et al., Successful reprogramming of differentiated cells by somatic cell nuclear transfer, using in vitro‐matured oocytes with a modified activation method. J Tissue Eng Regen Med, 2013. 7(11): p. 855‐63. SSM1 Literaturliste WS 2014/15
Savanna Smith (n1342091)
1.
Hirasawa R, Matoba S, Inoue K, Ogura A. Somatic donor cell type correlates with
embryonic, but not extra-embryonic, gene expression in postimplantation cloned embryos.
PloS one. 2013;8(10):e76422.
2.
Chen CH, Jiang BH, Huang SY, Yang TS, Lee KH, Tu CF, et al. Genetic
polymorphisms, growth performance, hematological parameters, serum enzymes, and
reproductive characteristics in phenotypically normal Landrace boars produced by somatic
cell nuclear transfer. Theriogenology. 2013;80(9):1088-96.
3.
Fulka J, Jr., Langerova A, Loi P, Ptak G, Albertini D, Fulka H. The ups and downs of
somatic cell nucleus transfer (SCNT) in humans. Journal of assisted reproduction and
genetics. 2013;30(8):1055-8.
4.
Hosseini SM, Moulavi F, Asgari V, Shirazi A, Abazari-Kia AH, Ghanaei HR, et al.
Simple, fast, and efficient method of manual oocyte enucleation using a pulled Pasteur
pipette. In vitro cellular & developmental biology Animal. 2013;49(8):569-75.
5.
Iuso D, Czernik M, Zacchini F, Ptak G, Loi P. A simplified approach for oocyte
enucleation in mammalian cloning. Cellular reprogramming. 2013;15(6):490-4.
6.
Kamimura S, Inoue K, Ogonuki N, Hirose M, Oikawa M, Yo M, et al. Mouse cloning
using a drop of peripheral blood. Biology of reproduction. 2013;89(2):24.
7.
Clark A. Human somatic cell nuclear transfer: a scientist's perspective. Molecular
reproduction and development. 2013;80(9):Fmi-Fmiii.
8.
Rodin S, Antonsson L, Hovatta O, Tryggvason K. Monolayer culturing and cloning of
human pluripotent stem cells on laminin-521-based matrices under xeno-free and chemically
defined conditions. Nature protocols. 2014;9(10):2354-68.
9.
Matsumura T, Tatsumi K, Noda Y, Nakanishi N, Okonogi A, Hirano K, et al. Singlecell cloning and expansion of human induced pluripotent stem cells by a microfluidic culture
device. Biochemical and biophysical research communications. 2014.
10.
Human somatic cell nuclear transfer and cloning. Fertility and sterility.
2012;98(4):804-7.
11.
Fan ZX, Zhu HB, Du WH. [Somatic cells reprogramming using cell extracts]. Yi chuan
= Hereditas / Zhongguo yi chuan xue hui bian ji. 2013;35(3):262-8.
12.
Liu J, Wang Y, Su J, Wang L, Li R, Li Q, et al. Effect of the time interval between
fusion and activation on epigenetic reprogramming and development of bovine somatic cell
nuclear transfer embryos. Cellular reprogramming. 2013;15(2):134-42.
Julian Seehauser 1. Wagner AM, Krenger W, Holzgreve W, Burkli P, Surbek DV. Use of human embryonic stem cells and umbilical cord blood stem cells for research and therapy: a prospective survey among health care professionals and patients in Switzerland. Transfusion. 2013;53(11):2681‐9. 2. Salem AM, Ahmed HH, Atta HM, Ghazy MA, Aglan HA. Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats. Cell biology international. 2014. 3. Piper SL, Wang M, Yamamoto A, Malek F, Luu A, Kuo AC, et al. Inducible immortality in hTERT‐human mesenchymal stem cells. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2012;30(12):1879‐85. 4. Niemann H, Lucas‐Hahn A. Somatic cell nuclear transfer cloning: practical applications and current legislation. Reproduction in domestic animals = Zuchthygiene. 2012;47 Suppl 5:2‐10. 5. Hwang I, Jeong YW, Kim JJ, Lee HJ, Kang M, Park KB, et al. Successful cloning of coyotes through interspecies somatic cell nuclear transfer using domestic dog oocytes. Reproduction, fertility, and development. 2013;25(8):1142‐8. 6. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 7. Miyazaki K, Maruyama T. Partial regeneration and reconstruction of the rat uterus through recellularization of a decellularized uterine matrix. Biomaterials. 2014;35(31):8791‐800. 8. Matsumura T, Tatsumi K, Noda Y, Nakanishi N, Okonogi A, Hirano K, et al. Single‐cell cloning and expansion of human induced pluripotent stem cells by a microfluidic culture device. Biochemical and biophysical research communications. 2014. 9. An L, Yuan Y, Yu B, Yang T, Cheng Y. [Cloning goat producing human lactoferrin with genetically modified donor cells selected by single or dual markers]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology. 2012;28(12):1482‐91. 10. Wells DN. Keith's MAGIC: Cloning and the Cell Cycle. Cellular reprogramming. 2013;15(5):348‐55. 11. Langlois A. Negotiating Bioethics: The Governance of UNESCO's Bioethics Programme. London and New York: Routledge (c) 2013 Adele Langlois.; 2013. 12. Cibelli JB. Human somatic cell nuclear transfer is alive and well. Cell stem cell. 2014;14(6):699‐701. 13. Ratajczak MZ, Marycz K, Poniewierska‐Baran A, Fiedorowicz K, Zbucka‐Kretowska M, Moniuszko M. Very small embryonic‐like stem cells as a novel developmental concept and the hierarchy of the stem cell compartment. Advances in medical sciences. 2014;59(2):273‐80. 14. Fulka J, Jr., Langerova A, Loi P, Ptak G, Albertini D, Fulka H. The ups and downs of somatic cell nucleus transfer (SCNT) in humans. Journal of assisted reproduction and genetics. 2013;30(8):1055‐8. 15. Horwitz M, Auquier P, Barlogis V, Contet A, Poiree M, Kanold J, et al. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study. British journal of haematology. 2014. Literaturliste SSM1 Maria Stiller 1. Crowe N. Cancer, conflict, and the development of nuclear transplantation techniques. Journal of the history of biology. 2014;47(1):63‐105. 2. Rodriguez RM, Ross PJ, Cibelli JB. Therapeutic cloning and cellular reprogramming. Advances in experimental medicine and biology. 2012;741:276‐89. 3. Moeinifar M, Ardebeli FA. Lineage and the rights of cloned child in the islamic jurisprudence. Journal of reproduction & infertility. 2012;13(4):183‐92. 4. Kim HM, Cho YS, Kim H, Jho S, Son B, Choi JY, et al. Whole genome comparison of donor and cloned dogs. Scientific reports. 2013;3:2998. 5. Fulka J, Jr., Langerova A, Loi P, Ptak G, Albertini D, Fulka H. The ups and downs of somatic cell nucleus transfer (SCNT) in humans. Journal of assisted reproduction and genetics. 2013;30(8):1055‐8. 6. Human somatic cell nuclear transfer and cloning. Fertility and sterility. 2012;98(4):804‐7. 7. Zhao J, Whyte J, Prather RS. Effect of epigenetic regulation during swine embryogenesis and on cloning by nuclear transfer. Cell and tissue research. 2010;341(1):13‐21. 8. Stobel‐Richter Y, Goldschmidt S, Brahler E, Weidner K, Beutel M. Egg donation, surrogate mothering, and cloning: attitudes of men and women in Germany based on a representative survey. Fertility and sterility. 2009;92(1):124‐30. 9. Baylis F. For love or money? The saga of Korean women who provided eggs for embryonic stem cell research. Theoretical medicine and bioethics. 2009;30(5):385‐96. 10. An L, Yuan Y, Yu B, Yang T, Cheng Y. [Cloning goat producing human lactoferrin with genetically modified donor cells selected by single or dual markers]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology. 2012;28(12):1482‐91. 11. Samiec M, Skrzyszowska M. The possibilities of practical application of transgenic mammalian species generated by somatic cell cloning in pharmacology, veterinary medicine and xenotransplantology. Polish journal of veterinary sciences. 2011;14(2):329‐40. 12. Lo B, Parham L, Alvarez‐Buylla A, Cedars M, Conklin B, Fisher S, et al. Cloning mice and men: prohibiting the use of iPS cells for human reproductive cloning. Cell stem cell. 2010;6(1):16‐20. 13. Vogel G. Stem cells. Therapeutic cloning reaches milestone. Science (New York, NY). 2014;344(6183):462‐3. Literaturliste: Ruth Baumgartner 1. Pfeiffer MJ, Esteves TC, Balbach ST, Arauzo‐Bravo MJ, Stehling M, Jauch A, et al. Reprogramming of two somatic nuclei in the same ooplasm leads to pluripotent embryonic stem cells. Stem cells (Dayton, Ohio). 2013;31(11):2343‐53. 2. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 3. Zhou W, Wang K, Ruan W, Bo Z, Liu L, Cao Z, et al. Higher methylation in genomic DNA indicates incomplete reprogramming in induced pluripotent stem cells. Cellular reprogramming. 2013;15(1):92‐9. 4. Tsai SC, Chang DF, Hong CM, Xia P, Senadheera D, Trump L, et al. Induced overexpression of OCT4A in human embryonic stem cells increases cloning efficiency. American journal of physiology Cell physiology. 2014;306(12):C1108‐18. 5. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007;450(7169):497‐502. 6. Cram DS, Song B, Trounson AO. Genotyping of Rhesus SCNT pluripotent stem cell lines. Nature. 2007;450(7169):E12‐4. 7. Hurlbut WB. Ethics and embryonic stem cell research: altered nuclear transfer as a way forward. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 2007;21(2):79‐83. 8. Condic ML, Rao M. Regulatory issues for personalized pluripotent cells. Stem cells (Dayton, Ohio). 2008;26(11):2753‐8. 9. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 10. Monzani PS, Sangalli JR, De Bem TH, Bressan FF, Fantinato‐Neto P, Pimentel JR, et al. Breeding of transgenic cattle for human coagulation factor IX by a combination of lentiviral system and cloning. Genetics and molecular research : GMR. 2013;12(3):3675‐88. 11. An L, Yuan Y, Yu B, Yang T, Cheng Y. [Cloning goat producing human lactoferrin with genetically modified donor cells selected by single or dual markers]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology. 2012;28(12):1482‐91. 12. Wan YJ, Zhang YL, Zhou ZR, Jia RX, Li M, Song H, et al. Efficiency of donor cell preparation and recipient oocyte source for production of transgenic cloned dairy goats harboring human lactoferrin. Theriogenology. 2012;78(3):583‐92. 13. Kobolak J, Bodo S, Rungsiwiwut R, Meng Q, Adorjan M, Virutamasen P, et al. Generation of mouse embryonic stem cell lines from zona‐free nuclear transfer embryos. Cellular reprogramming. 2010;12(1):105‐13. 14. Zhang YL, Wan YJ, Wang ZY, Xu D, Pang XS, Meng L, et al. Production of dairy goat embryos, by nuclear transfer, transgenic for human acid beta‐glucosidase. Theriogenology. 2010;73(5):681‐90. 15. Wei Y, Zhu J, Huan Y, Liu Z, Yang C, Zhang X, et al. Aberrant expression and methylation status of putatively imprinted genes in placenta of cloned piglets. Cellular reprogramming. 2010;12(2):213‐
22. (1‐15) Literaturliste Michael Turner 1. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 2. Chung YG, Eum JH, Lee JE, Shim SH, Sepilian V, Hong SW, et al. Human somatic cell nuclear transfer using adult cells. Cell stem cell. 2014;14(6):777‐80. 3. Yu Y, Yan J, Zhang Q, Yan L, Li M, Zhou Q, et al. Successful reprogramming of differentiated cells by somatic cell nuclear transfer, using in vitro‐matured oocytes with a modified activation method. Journal of tissue engineering and regenerative medicine. 2013;7(11):855‐63. 4. Noggle S, Fung HL, Gore A, Martinez H, Satriani KC, Prosser R, et al. Human oocytes reprogram somatic cells to a pluripotent state. Nature. 2011;478(7367):70‐5. 5. Tachibana M, Sparman M, Mitalipov S. Chromosome transfer in mature oocytes. Nature protocols. 2010;5(6):1138‐47. 6. Mitalipov S, Wolf DP. Clinical and ethical implications of mitochondrial gene transfer. Trends in endocrinology and metabolism: TEM. 2014;25(1):5‐7. 7. Amato P, Tachibana M, Sparman M, Mitalipov S. Three‐parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases. Fertility and sterility. 2014;101(1):31‐5. 8. Tachibana M, Amato P, Sparman M, Woodward J, Sanchis DM, Ma H, et al. Towards germline gene therapy of inherited mitochondrial diseases. Nature. 2013;493(7434):627‐31. 9. Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 2014;510(7506):533‐6. 10. Paull D, Emmanuele V, Weiss KA, Treff N, Stewart L, Hua H, et al. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature. 2013;493(7434):632‐7. 11. Kahler DJ, Ahmad FS, Ritz A, Hua H, Moroziewicz DN, Sproul AA, et al. Improved methods for reprogramming human dermal fibroblasts using fluorescence activated cell sorting. PloS one. 2013;8(3):e59867. 12. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 13. Chinnery PF, Craven L, Mitalipov S, Stewart JB, Herbert M, Turnbull DM. The challenges of mitochondrial replacement. PLoS genetics. 2014;10(4):e1004315. 14. Cohen NM, Dighe V, Landan G, Reynisdottir S, Palsson A, Mitalipov S, et al. DNA methylation programming and reprogramming in primate embryonic stem cells. Genome research. 2009;19(12):2193‐201. 15. Astolfi PA, Salamini F, Sgaramella V. Are we Genomic Mosaics? Variations of the Genome of Somatic Cells can Contribute to Diversify our Phenotypes. Current genomics. 2010;11(6):379‐86. SSM1 Literaturliste Nina Loschko 1. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 2. Li F, Cao H, Zhang Q, Li R, Chen X, Fang Z, et al. Activation of human embryonic gene expression in cytoplasmic hybrid embryos constructed between bovine oocytes and human fibroblasts. Cloning and stem cells. 2008;10(3):297‐305. 3. Chung YG, Eum JH, Lee JE, Shim SH, Sepilian V, Hong SW, et al. Human somatic cell nuclear transfer using adult cells. Cell stem cell. 2014;14(6):777‐80. 4. Fan Y, Jiang Y, Chen X, Ou Z, Yin Y, Huang S, et al. Derivation of cloned human blastocysts by histone deacetylase inhibitor treatment after somatic cell nuclear transfer with beta‐thalassemia fibroblasts. Stem cells and development. 2011;20(11):1951‐9. 5. French AJ, Adams CA, Anderson LS, Kitchen JR, Hughes MR, Wood SH. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem cells (Dayton, Ohio). 2008;26(2):485‐93. 6. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 7. Ostrup O, Strejcek F, Petrovicova I, Lucas‐Hahn A, Morovic M, Lemme E, et al. Role of ooplasm in nuclear and nucleolar remodeling of intergeneric somatic cell nuclear transfer embryos during the first cell cycle. Cellular reprogramming. 2011;13(2):145‐55. 8. Narbonne P, Miyamoto K, Gurdon JB. Reprogramming and development in nuclear transfer embryos and in interspecific systems. Current opinion in genetics & development. 2012;22(5):450‐8. 9. Li J, Liu X, Wang H, Zhang S, Liu F, Wang X, et al. Human embryos derived by somatic cell nuclear transfer using an alternative enucleation approach. Cloning and stem cells. 2009;11(1):39‐50. 10. Fulka J, Jr., Langerova A, Loi P, Ptak G, Albertini D, Fulka H. The ups and downs of somatic cell nucleus transfer (SCNT) in humans. Journal of assisted reproduction and genetics. 2013;30(8):1055‐8. 11. Fulka J, Jr., Fulka H. Somatic cell nuclear transfer (SCNT) in mammals: the cytoplast and its reprogramming activities. Advances in experimental medicine and biology. 2007;591:93‐102. 12. Langerova A, Fulka H, Fulka J, Jr. Somatic cell nuclear transfer‐derived embryonic stem cell lines in humans: pros and cons. Cellular reprogramming. 2013;15(6):481‐3. 13. Firas J, Liu X, Polo JM. Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: Evidence and implications. Differentiation; research in biological diversity. 2014. 14. Wakayama S, Mizutani E, Wakayama T. Production of cloned mice from somatic cells, ES cells, and frozen bodies. Methods in enzymology. 2010;476:151‐69. 15. Thuan NV, Kishigami S, Wakayama T. How to improve the success rate of mouse cloning technology. The Journal of reproduction and development. 2010;56(1):20‐30. 16. Al‐Aqeel AI. Human cloning, stem cell research. An Islamic perspective. Saudi medical journal. Sebastian Pauer 1. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663‐76. 3. Wang T, Sha H, Ji D, Zhang HL, Chen D, Cao Y, et al. Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell. 2014;157(7):1591‐604. 4. Tsai SC, Chang DF, Hong CM, Xia P, Senadheera D, Trump L, et al. Induced overexpression of OCT4A in human embryonic stem cells increases cloning efficiency. American journal of physiology Cell physiology. 2014;306(12):C1108‐18. 5. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 6. Ieda M. Direct reprogramming into desired cell types by defined factors. The Keio journal of medicine. 2013;62(3):74‐82. 7. Hongwei S, Tiezhu A, Shanhua P, Chunsheng W. [Mammalian DNA methylation and its roles during the induced re‐programming of somatic cells]. Yi chuan = Hereditas / Zhongguo yi chuan xue hui bian ji. 2014;36(5):431‐8. 8. Okahara‐Narita J, Umeda R, Nakamura S, Mori T, Noce T, Torii R. Induction of pluripotent stem cells from fetal and adult cynomolgus monkey fibroblasts using four human transcription factors. Primates; journal of primatology. 2012;53(2):205‐13. 9. Basma H, Gunji Y, Iwasawa S, Nelson A, Farid M, Ikari J, et al. Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells. American journal of physiology Lung cellular and molecular physiology. 2014;306(6):L552‐65. 10. Shipony Z, Mukamel Z, Cohen NM, Landan G, Chomsky E, Zeliger SR, et al. Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature. 2014;513(7516):115‐9. 11. Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 2014;156(4):663‐77. 12. Lim J, Kim J, Kang J, Jo D. Partial somatic to stem cell transformations induced by cell‐
permeable reprogramming factors. Scientific reports. 2014;4:4361. 13. Rodriguez‐Osorio N, Urrego R, Cibelli JB, Eilertsen K, Memili E. Reprogramming mammalian somatic cells. Theriogenology. 2012;78(9):1869‐86. 14. Takasato M, Vanslambrouck JM, Little MH. Reprogramming Somatic Cells to a Kidney Fate. Seminars in nephrology. 2014;34(4):462‐80. 15. Clausen J. Stem cells, nuclear transfer and respect for embryos. Human reproduction and genetic ethics. 2010;16(1):48‐59. (Sonnleitner) 1. Paull D, Emmanuele V, Weiss KA, Treff N, Stewart L, Hua H, et al. Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants. Nature. 2013;493(7434):632‐7. 2. Firas J, Liu X, Polo JM. Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: Evidence and implications. Differentiation. 2014. 3. Liu J, Wang Y, Su J, Luo Y, Quan F, Zhang Y. Nuclear donor cell lines considerably influence cloning efficiency and the incidence of large offspring syndrome in bovine somatic cell nuclear transfer. Reprod Domest Anim. 2013;48(4):660‐4. 4. Duan L, Wang Z, Shen J, Shan Z, Shen X, Wu Y, et al. Comparison of reprogramming genes in induced pluripotent stem cells and nuclear transfer cloned embryos. Stem Cell Rev. 2014;10(4):548‐
60. 5. Sung LY, Chang CC, Amano T, Lin CJ, Amano M, Treaster SB, et al. Efficient derivation of embryonic stem cells from nuclear transfer and parthenogenetic embryos derived from cryopreserved oocytes. Cell Reprogram. 2010;12(2):203‐11. 6. Yu Y, Yan J, Zhang Q, Yan L, Li M, Zhou Q, et al. Successful reprogramming of differentiated cells by somatic cell nuclear transfer, using in vitro‐matured oocytes with a modified activation method. J Tissue Eng Regen Med. 2013;7(11):855‐63. 7. Fulka J, Jr., Langerova A, Loi P, Ptak G, Albertini D, Fulka H. The ups and downs of somatic cell nucleus transfer (SCNT) in humans. J Assist Reprod Genet. 2013;30(8):1055‐8. 8. Fan Y, Jiang Y, Chen X, Ou Z, Yin Y, Huang S, et al. Derivation of cloned human blastocysts by histone deacetylase inhibitor treatment after somatic cell nuclear transfer with beta‐thalassemia fibroblasts. Stem Cells Dev. 2011;20(11):1951‐9. 9. Pfeiffer MJ, Esteves TC, Balbach ST, Arauzo‐Bravo MJ, Stehling M, Jauch A, et al. Reprogramming of two somatic nuclei in the same ooplasm leads to pluripotent embryonic stem cells. Stem Cells. 2013;31(11):2343‐53. 10. Kang E, Wu G, Ma H, Li Y, Tippner‐Hedges R, Tachibana M, et al. Nuclear reprogramming by interphase cytoplasm of two‐cell mouse embryos. Nature. 2014;509(7498):101‐4. 11. Jin JX, Li S, Gao QS, Hong Y, Jin L, Zhu HY, et al. Significant improvement of pig cloning efficiency by treatment with LBH589 after somatic cell nuclear transfer. Theriogenology. 2013;80(6):630‐5. 12. Rodriguez RM, Ross PJ, Cibelli JB. Therapeutic cloning and cellular reprogramming. Adv Exp Med Biol. 2012;741:276‐89. 13. Yang J, Liu GQ, Hong TP. [Therapeutic cloning and somatic cell reprogramming: every road leads to Rome]. Sheng Li Ke Xue Jin Zhan. 2009;40(2):101‐5. Literaturliste David Pereyra
(1-15)
1. Feng X, Cao S, Wang H, Meng C, Li J, Jiang J, et al. Production of transgenic dairy goat expressing human alpha‐lactalbumin by somatic cell nuclear transfer. Transgenic research. 2014. 2. Chung YG, Eum JH, Lee JE, Shim SH, Sepilian V, Hong SW, et al. Human somatic cell nuclear transfer using adult cells. Cell stem cell. 2014;14(6):777‐80. 3. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 4. Dorfeshan P, Salehnia M, Moazzeni SM. Ovarian stimulation affects the population of mouse uterine NK cells at early pregnancy. BioMed research international. 2013;2013:182531. 5. Weinerman R, Mainigi M. Why we should transfer frozen instead of fresh embryos: the translational rationale. Fertility and sterility. 2014;102(1):10‐8. 6. Takasato M, Vanslambrouck JM, Little MH. Reprogramming Somatic Cells to a Kidney Fate. Seminars in nephrology. 2014;34(4):462‐80. 7. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 8. Sparrow R. Therapeutic cloning and reproductive liberty. The Journal of medicine and philosophy. 2009;34(2):102‐18. 9. Sandler R. The ethics of reviving long extinct species. Conservation biology : the journal of the Society for Conservation Biology. 2014;28(2):354‐60. 10. Polejaeva IA, Broek DM, Walker SC, Zhou W, Walton M, Benninghoff AD, et al. Longitudinal study of reproductive performance of female cattle produced by somatic cell nuclear transfer. PloS one. 2013;8(12):e84283. 11. Medicine ECotASfR. Human somatic cell nuclear transfer and cloning. Fertility and sterility. 2012;98(4):804‐7. 12. Lee JH, Maalouf WE. Nuclear transfer in ruminants. Methods in molecular biology (Clifton, NJ). 2015;1222:25‐36. 13. Estrov Z. Stem cells and somatic cells: reprogramming and plasticity. Clinical lymphoma & myeloma. 2009;9 Suppl 3:S319‐28. 14. de Oliveira Junior EQ, de Oliveira PB. Protection of genetic heritage in the era of cloning. Revista brasileira de hematologia e hemoterapia. 2012;34(6):452‐8. 15. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007;450(7169):497‐502. SSM1 Literaturliste – Rathmair Franz (1‐16) 1. Dickenson DL, inventorThe commercialization of human eggs in mitochondrial replacement research patent 2050‐2877 (Print) 2050‐2877. 2013. 2. Amato P, Tachibana M, Sparman M, Mitalipov S. Three‐parent in vitro fertilization: gene replacement for the prevention of inherited mitochondrial diseases. Fertility and sterility. 2014;101(1):31‐5. 3. Isasi RM, Knoppers BM, Singer PA, Daar AS. Legal and ethical approaches to stem cell and cloning research: a comparative analysis of policies in Latin America, Asia, and Africa. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 2004;32(4):626‐
40. 4. Ellison B, Meliker J. Assessing the risk of ovarian hyperstimulation syndrome in egg donation: implications for human embryonic stem cell research. The American journal of bioethics : AJOB. 2011;11(9):22‐30. 5. Schenker JG. Human reproduction: Jewish perspectives. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2013;29(11):945‐8. 6. Ford NM. A Catholic ethical approach to human reproductive technology. Reproductive biomedicine online. 2008;17 Suppl 3:39‐48. 7. Al‐Aqeel AI. Human cloning, stem cell research. An Islamic perspective. Saudi medical journal. 2009;30(12):1507‐14. 8. Zavos PM, Illmensee K. Possible therapy of male infertility by reproductive cloning: one cloned human 4‐cell embryo. Archives of andrology. 2006;52(4):243‐54. 9. Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 2014;510(7506):533‐6. 10. Shapshay S. Procreative liberty, enhancement and commodification in the human cloning debate. Health care analysis : HCA : journal of health philosophy and policy. 2012;20(4):356‐66. 11. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 12. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 13. Singer P. The harm that religion does. Free inquiry (Buffalo, NY). 2004;24(4):17, 58. 14. Mitalipov S, Wolf DP. Clinical and ethical implications of mitochondrial gene transfer. Trends in endocrinology and metabolism: TEM. 2014;25(1):5‐7. 15. Langlois A. Negotiating Bioethics: The Governance of UNESCO's Bioethics Programme. London and New York: Routledge (c) 2013 Adele Langlois.; 2013. 16. Daar AS, Bhatt A, Court E, Singer PA. Stem cell research and transplantation: science leading ethics. Transplantation proceedings. 2004;36(8):2504‐6. Literaturliste in folgender Reihenfolge: (Kupitz) 1. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 2. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 3. Lang JY, Shi Y, Chin YE. Reprogramming cancer cells: back to the future. Oncogene. 2013;32(18):2247‐8. 4. Jiang J, Lv W, Ye X, Wang L, Zhang M, Yang H, et al. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell research. 2013;23(1):92‐106. 5. Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 2014;510(7506):533‐6. 6. Li Y, Li X, Zhao H, Feng R, Zhang X, Tai D, et al. Efficient induction of pluripotent stem cells from menstrual blood. Stem cells and development. 2013;22(7):1147‐58. 7. Jones DA. Is the creation of admixed embryos "an offense against human dignity"? Human reproduction and genetic ethics. 2010;16(1):87‐114. 8. Gonzalez‐Munoz E, Arboleda‐Estudillo Y, Otu HH, Cibelli JB. Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming. Science (New York, NY). 2014;345(6198):822‐5. 9. Wang T, Shi SB, Sha HY. MicroRNAs in regulation of pluripotency and somatic cell reprogramming: small molecule with big impact. RNA biology. 2013;10(8):1255‐61. 10. Tachibana M, Amato P, Sparman M, Woodward J, Sanchis DM, Ma H, et al. Towards germline gene therapy of inherited mitochondrial diseases. Nature. 2013;493(7434):627‐31. 11. Steichen C, Luce E, Maluenda J, Tosca L, Moreno‐Gimeno I, Desterke C, et al. Messenger RNA‐ versus retrovirus‐based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity. Stem cells translational medicine. 2014;3(6):686‐91. 12. Lim J, Kim J, Kang J, Jo D. Partial somatic to stem cell transformations induced by cell‐
permeable reprogramming factors. Scientific reports. 2014;4:4361. 13. Wapinski OL, Vierbuchen T, Qu K, Lee QY, Chanda S, Fuentes DR, et al. Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. Cell. 2013;155(3):621‐35. 14. Lorthongpanich C, Cheow LF, Balu S, Quake SR, Knowles BB, Burkholder WF, et al. Single‐cell DNA‐methylation analysis reveals epigenetic chimerism in preimplantation embryos. Science (New York, NY). 2013;341(6150):1110‐2. 15. Lomax GP, DeWitt ND. Somatic cell nuclear transfer in Oregon: expanding the pluripotent space and informing research ethics. Stem cells and development. 2013;22 Suppl 1:25‐8. Literaturliste Ramic Lejla 1. Oh HJ, Kim MK, Jang G, Kim HJ, Hong SG, Park JE, et al. Cloning endangered gray wolves (Canis lupus) from somatic cells collected postmortem. Theriogenology. 2008;70(4):638‐47. 2. Firas J, Liu X, Polo JM. Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: Evidence and implications. Differentiation; research in biological diversity. 2014. 3. Fadel HE. Developments in stem cell research and therapeutic cloning: Islamic ethical positions, a review. Bioethics. 2012;26(3):128‐35. 4. Birnbacher D. Human cloning and human dignity. Reproductive biomedicine online. 2005;10 Suppl 1:50‐5. 5. Camporesi S, Bortolotti L. Reproductive cloning in humans and therapeutic cloning in primates: is the ethical debate catching up with the recent scientific advances? Journal of medical ethics. 2008;34(9):e15. 6. Canepa MJ, Ortega NM, Monteleone MC, Mucci N, Kaiser GG, Brocco M, et al. Expression profile of genes as indicators of developmental competence and quality of in vitro fertilization and somatic cell nuclear transfer bovine embryos. PloS one. 2014;9(9):e108139. 7. Cohen NM, Dighe V, Landan G, Reynisdottir S, Palsson A, Mitalipov S, et al. DNA methylation programming and reprogramming in primate embryonic stem cells. Genome research. 2009;19(12):2193‐201. 8. de Oliveira Junior EQ, de Oliveira PB. Protection of genetic heritage in the era of cloning. Revista brasileira de hematologia e hemoterapia. 2012;34(6):452‐8. 9. Tachibana M, Sparman M, Mitalipov S. Chromosome transfer in mature oocytes. Fertility and sterility. 2012;97(5):e16. 10. Hook CC. In vitro fertilization and stem cell harvesting from human embryos: the law and practice in the United States. Polskie Archiwum Medycyny Wewnetrznej. 2010;120(7‐8):282‐9. 11. Kang E, Wu G, Ma H, Li Y, Tippner‐Hedges R, Tachibana M, et al. Nuclear reprogramming by interphase cytoplasm of two‐cell mouse embryos. Nature. 2014;509(7498):101‐4. 12. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, et al. Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature. 2014;511(7508):177‐83. 13. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 14. Smith LC, Bordignon V, Babkine M, Fecteau G, Keefer C. Benefits and problems with cloning animals. The Canadian veterinary journal La revue veterinaire canadienne. 2000;41(12):919‐24. 15. Tachezy R, Duson G, Rector A, Jenson AB, Sundberg JP, Van Ranst M. Cloning and genomic characterization of Felis domesticus papillomavirus type 1. Virology. 2002;301(2):313‐21. (1-15) (Dabovic)
1. Human somatic cell nuclear transfer and cloning. Fertility and sterility. 2012;98(4):804‐7. 2. Cameron C, Williamson R. In the world of Dolly, when does a human embryo acquire respect? Journal of medical ethics. 2005;31(4):215‐20. 3. Caulfield T. Human cloning laws, human dignity and the poverty of the policy making dialogue. BMC medical ethics. 2003;4:E3. 4. Devolder K. To be, or not to be? Are induced pluripotent stem cells potential babies, and does it matter? EMBO reports. 2009;10(12):1285‐7. 5. Fulka J, Jr., Langerova A, Loi P, Ptak G, Albertini D, Fulka H. The ups and downs of somatic cell nucleus transfer (SCNT) in humans. Journal of assisted reproduction and genetics. 2013;30(8):1055‐8. 6. Green RM. Confronting rationality. Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees. 2011;20(2):216‐27. 7. Lim J, Kim J, Kang J, Jo D. Partial somatic to stem cell transformations induced by cell‐
permeable reprogramming factors. Scientific reports. 2014;4:4361. 8. Martinez‐Fernandez A, Nelson TJ, Terzic A. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells. Journal of cardiovascular translational research. 2011;4(2):131‐7. 9. Polkinghorne JC. The person, the soul, and genetic engineering. Journal of medical ethics. 2004;30(6):593‐7; discussion 7‐600. 10. Ramalho‐Santos J. Human procreation in unchartered territory: new twists in ethical discussions. Human reproduction (Oxford, England). 2011;26(6):1284‐7. 11. St John JC, Facucho‐Oliveira J, Jiang Y, Kelly R, Salah R. Mitochondrial DNA transmission, replication and inheritance: a journey from the gamete through the embryo and into offspring and embryonic stem cells. Human reproduction update. 2010;16(5):488‐509. 12. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner‐Hedges R, Ma H, et al. Human embryonic stem cells derived by somatic cell nuclear transfer. Cell. 2013;153(6):1228‐38. 13. Taebi B, Kloosterman JL. To recycle or not to recycle? An intergenerational approach to nuclear fuel cycles. Science and engineering ethics. 2008;14(2):177‐200. 14. Takahashi K. Cellular reprogramming. Cold Spring Harbor perspectives in biology. 2014;6(2). 15. Whitworth KM, Prather RS. Somatic cell nuclear transfer efficiency: how can it be improved through nuclear remodeling and reprogramming? Molecular reproduction and development. 2010;77(12):1001‐15. 
Herunterladen